Cleveland Clinic-Led Trial: Cholesterol Drug Reduces Heart Events, Including Death
Cleveland Clinic-Led Trial Shows that Cholesterol-Lowering Drug Reduces Heart-Related Events, Including Death, in Statin-Intolerant Patients with Elevated Cardiovascular Risk Findings from a Cleveland Clinic-led clinical trial showed that the use of bempedoic acid (a cholesterol-lowering drug) in statin-intolerant patients – who have not yet had a cardiovascular event, but do have risk factors, like diabetes …
Cleveland Clinic-Led Trial: Cholesterol Drug Reduces Heart Events, Including Death Read More »